Literature DB >> 6843359

Arginine-induced glucagon secretion in the spontaneously diabetic BB Wistar rat.

P Poussier, A F Nakhooda, M Grose, E B Marliss.   

Abstract

The spontaneously diabetic BB Wistar rat shows many characteristics analogous to human insulin-dependent diabetes (IDDM). These include inappropriately normal immunoreactive glucagon in the presence of hyperglycemia, absolute hyperglucagonemia with severe ketosis, and hyperresponsiveness to exogenous arginine in vivo. We used an in situ pancreas preparation to further study portal vein glucagon responses to intravenous arginine. In normal rats, magnitude of response was correlated with prestimulation levels. Basal levels were significantly increased in hyperglycemic diabetics compared to controls, but responses to arginine were attenuated in both absolute and relative terms. Comparisons of responses with poor and good prior diabetes control showed no significant differences. Thus, a further anomaly of glucagon secretion has been identified in these rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843359     DOI: 10.1016/0026-0495(83)90011-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Liver perisinusoidal fibrosis in BB rats with or without overt diabetes.

Authors:  D Bernuau; R Guillot; A M Durand-Schneider; P Poussier; A Moreau; G Feldmann
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

Review 2.  Altered immunity and diabetes in the BB rat.

Authors:  J F Yale; E B Marliss
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

3.  Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate.

Authors:  M Tominaga; I Komiya; J H Johnson; L Inman; T Alam; J Moltz; B Crider; Y Stefan; D Baetens; K McCorkle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.